Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EVKG Ever-Glory International Group	$0.00	$0.00	$0.00 ▼ $0.01	$10K	3.82	18,100 shs	300,000 shs
LULU Lululemon Athletica	$310.76 -3.0%	$286.26	$226.01 ▼ $423.32	$37.49B	1.3	2.17 million shs	1.99 million shs
MGOL MGO Global	$0.31 -33.8%	$0.31	$0.10 ▼ $17.30	$894K	7.26	22.52 million shs	106.10 million shs
SILO Silo Pharma	$0.43 +0.3%	$0.97	$0.41 ▼ $4.50	$1.92M	0.37	2.22 million shs	165,485 shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EVKG Ever-Glory International Group	0.00%	0.00%	0.00%	0.00%	-12.50%
LULU Lululemon Athletica	-3.03%	-3.32%	+16.88%	-13.43%	+3.71%
MGOL MGO Global	0.00%	0.00%	0.00%	0.00%	-97.34%
SILO Silo Pharma	+0.28%	-11.26%	-63.03%	-68.23%	-81.35%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LULU Lululemon Athletica	3.8342 of 5 stars	3.3	2.0	0.0	1.7	2.8	1.7	1.9
MGOL MGO Global	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SILO Silo Pharma	0.3133 of 5 stars	0.0	2.0	0.0	0.0	2.5	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EVKG Ever-Glory International Group	0.00	N/A	N/A	N/A
LULU Lululemon Athletica	2.65	Moderate Buy	$368.72	18.65% Upside
MGOL MGO Global	0.00	N/A	N/A	N/A
SILO Silo Pharma	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest SILO, MGOL, EVKG, and LULU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/12/2025	LULU Lululemon Athletica	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$309.00 ➝ $276.00
4/30/2025	LULU Lululemon Athletica	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$315.00 ➝ $300.00
4/28/2025	LULU Lululemon Athletica	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$330.00 ➝ $275.00
4/22/2025	LULU Lululemon Athletica	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$363.00 ➝ $302.00
4/14/2025	LULU Lululemon Athletica	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$391.00 ➝ $389.00
4/11/2025	LULU Lululemon Athletica	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$315.00 ➝ $280.00
4/10/2025	LULU Lululemon Athletica	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$424.00 ➝ $353.00
4/9/2025	LULU Lululemon Athletica	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$380.00 ➝ $297.00
4/4/2025	LULU Lululemon Athletica	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$450.00 ➝ $370.00
4/3/2025	LULU Lululemon Athletica	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform

(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A	N/A
LULU Lululemon Athletica	$10.59B	3.54	$13.47 per share	23.07	$33.53 per share	9.27
MGOL MGO Global	$5.20M	0.17	N/A	N/A	$0.64 per share	0.48
SILO Silo Pharma	$72.10K	26.67	N/A	N/A	$2.14 per share	0.20

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EVKG Ever-Glory International Group	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
LULU Lululemon Athletica	$1.55B	$14.70	22.44	20.21	2.22	17.05%	42.16%	25.02%	6/5/2025 (Confirmed)
MGOL MGO Global	-$7.14M	-$4.57	N/A	∞	N/A	-142.93%	-412.85%	-291.72%	N/A
SILO Silo Pharma	-$3.70M	-$1.17	N/A	∞	N/A	-5,255.05%	-61.38%	-47.49%	8/11/2025 (Estimated)

Latest SILO, MGOL, EVKG, and LULU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
6/5/2025	Q1 2026	LULU Lululemon Athletica	$2.60	N/A	N/A	N/A	$2.36 billion	N/A
5/9/2025	Q1 2025	SILO Silo Pharma	N/A	-$0.23	N/A	-$0.23	N/A	$0.02 million
3/28/2025	Q4 2024	SILO Silo Pharma	N/A	-$0.41	N/A	-$0.41	N/A	$0.02 million
3/27/2025	Q4 2025	LULU Lululemon Athletica	$5.85	$6.14	+$0.29	$6.14	$3.59 billion	$3.60 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A
LULU Lululemon Athletica	N/A	N/A	N/A	N/A	N/A
MGOL MGO Global	N/A	N/A	N/A	N/A	N/A
SILO Silo Pharma	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EVKG Ever-Glory International Group	N/A	N/A	N/A
LULU Lululemon Athletica	N/A	2.00	1.00
MGOL MGO Global	N/A	14.13	8.37
SILO Silo Pharma	N/A	7.91	7.91

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EVKG Ever-Glory International Group	N/A
LULU Lululemon Athletica	85.20%
MGOL MGO Global	1.05%
SILO Silo Pharma	5.58%

Insider Ownership

Company	Insider Ownership
EVKG Ever-Glory International Group	35.53%
LULU Lululemon Athletica	0.54%
MGOL MGO Global	12.60%
SILO Silo Pharma	4.37%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EVKG Ever-Glory International Group	4,300	14.66 million	N/A	Not Optionable
LULU Lululemon Athletica	29,000	120.64 million	121.20 million	Optionable
MGOL MGO Global	7	2.90 million	2.54 million	Not Optionable
SILO Silo Pharma	2	4.48 million	4.29 million	Not Optionable

SILO, MGOL, EVKG, and LULU Headlines

Recent News About These Companies

Silo Pharma, Inc.: Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 23 at 6:43 AM | finanznachrichten.de

Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug

May 21 at 7:58 PM | msn.com

Silo Pharma, Inc. Partners with Resyca BV for SPC-15 Drug-Device Study Aimed at PTSD Treatment

May 21 at 9:39 AM | quiverquant.com

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 21 at 8:55 AM | globenewswire.com

Silo Pharma, Inc.: Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 16, 2025 | finanznachrichten.de

Silo Pharma Signs With Frontage Labs For FDA Requested Safety Study Of SPC-15

May 16, 2025 | nasdaq.com

Silo Pharma Announces Closing of $2 Million Public Offering

May 16, 2025 | globenewswire.com

Silo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD Treatment

May 16, 2025 | msn.com

Silo Pharma, Inc. Prices Public Offering of 3,333,338 Shares with Associated Warrants

May 15, 2025 | quiverquant.com

Silo Pharma Announces Pricing of $2 Million Public Offering

May 15, 2025 | globenewswire.com

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 14, 2025 | globenewswire.com

Silo Pharma, Inc. Announces Agreement with Frontage Laboratories for SPC-15 Safety and Toxicology Study Targeting PTSD Treatment

May 14, 2025 | quiverquant.com

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

May 14, 2025 | globenewswire.com

Counterproposal to Swiss cost-cutting initiative

May 12, 2025 | thepharmaletter.com

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

April 30, 2025 | finance.yahoo.com

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

April 30, 2025 | globenewswire.com

Silo Pharma Files Patent Application for Alzheimer's Drug SPC-14 Targeting Novel Mechanism of Action

April 29, 2025 | nasdaq.com

Sarasota company applies for Alzheimer's drug patent

April 29, 2025 | businessobserverfl.com

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug

April 28, 2025 | finance.yahoo.com

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

April 28, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SILO, MGOL, EVKG, and LULU Company Descriptions

Ever-Glory International Group NASDAQ:EVKG

$0.0007 0.00 (0.00%)

As of 05/21/2025 03:21 PM Eastern

Ever-Glory International Group, Inc., together with its subsidiaries, manufactures, supplies, and retails apparel in Mainland China, Hong Kong, Germany, the United Kingdom, Europe, Japan, and the United States. It operates through two segments, Wholesale and Retail. The company primarily offers casual wear, outerwear, and sportswear. Its products include coats, jackets, slacks, skirts, shirts, trousers, and jeans for women; vests, jackets, trousers, skiwear, shirts, coats, and jeans for men; and coats, vests, down jackets, trousers, knitwear, and jeans for children. The company offers its woman apparel under the La go go, Velwin, Sea To Sky, Jizhu, and idole brands. It also engages in the import and export of apparel, fabric, and accessories. The company provides its products directly to consumers through retail stores, as well as online stores at Tmall, Dangdang mall, JD.com, VIP.com, etc. As of March 31, 2022, it operated 848 stores in China. The company is based in Nanjing, the Peoples Republic of China.

Lululemon Athletica NASDAQ:LULU

$310.76 -9.70 (-3.03%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$310.81 +0.05 (+0.02%)

As of 05/23/2025 07:59 PM Eastern

Lululemon Athletica Inc., together with its subsidiaries, designs, distributes, and retails athletic apparel, footwear, and accessories under the lululemon brand for women and men. It offers pants, shorts, tops, and jackets for healthy lifestyle, such as yoga, running, training, and other activities. It also provides fitness-inspired accessories. The company sells its products through a chain of company-operated stores; outlets; interactive workout platform; yoga and fitness studios, university campus retailers, and other partners; license and supply arrangements; and temporary locations, as well as through mobile apps and lululemon.com e-commerce website. It has operations in the United States, Canada, Mainland China, Australia, South Korea, Hong Kong, Japan, New Zealand, Taiwan, Singapore, Malaysia, Macau, Thailand, the Asia Pacific, the United Kingdom, Germany, France, Ireland, Spain, the Netherlands, Sweden, Norway, Switzerland, Europe, the Middle East, and Africa. Lululemon Athletica Inc. was founded in 1998 and is based in Vancouver, Canada.

MGO Global NASDAQ:MGOL

$0.31 -0.16 (-33.76%)

Closing price 02/19/2025

Extended Trading

$0.31 0.00 (0.00%)

As of 02/19/2025 08:00 PM Eastern

MGO Global, Inc. operates as a lifestyle brand portfolio company. The company is involved in the fashion design, brand development and management, sourcing and manufacturing, licensing, IP protection, corporate finance, consumer engagement and experience, ecommerce, and retail sales and marketing activities related to the Messi brand. MGO Global, Inc. was founded in 2018 and is headquartered in Fort Lauderdale, Florida.

Silo Pharma NASDAQ:SILO

$0.43 +0.00 (+0.28%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$0.42 -0.01 (-2.77%)

As of 05/23/2025 07:55 PM Eastern

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time